Eric Brown

Eric Brown

Company: Aprea Therapeutics

Job title: Co-Founder


Repli-Biom: a Novel Proteo-Genomic Approach to Identify Predictive Biomarkers of DDR Inhibitor Efficacy 12:00 pm

Repli-Biom combines proteomics, genomics, and synthetic lethality screens through computational approaches Through this analysis, Repli-Biom identifies and prioritizes predictive biomarkers of drug sensitivity This approach has now been used to identify novel biomarkers for ATR inhibitor treatmentsRead more

day: Day Two

© Copyright 2018 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.